BackLucid Diagnostics Overview
Lucid Diagnostics Inc

Lucid Diagnostics Target Price

Where could LUCD trade next? Consensus target price: $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.96

Average Target Price

$2.00107.3% upside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-15Maxim Group$2107.3% upsideOpen
2025-03-25BTIG$2107.3% upsideOpen
2024-11-13NeedhamMike Matson$2.5159.1% upsideOpen
2024-05-14Canaccord GenuityKyle Mikson$3210.9% upsideOpen
2024-04-08BTIGMark Massaro$2.5159.1% upsideOpen
2022-11-18BTIG$3.5262.7% upsideOpen
2022-11-15Needham$3.1221.3% upsideOpen

Lucid Diagnostics (LUCD) FAQ

Lucid Diagnostics (LUCD) currently reports a target price of $2. Use the charts on this page to explore Lucid Diagnostics's target price history and peer comparisons.

Analysts' average 12-month price target for Lucid Diagnostics is $2, about 107.3% upside from the current share price of $0.96. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $2, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lucid Diagnostics, and consider following LUCD for alerts when major investors trade the stock.